A Multi-center, International Prospective Follow up Study
A Multi-center, International Prospective Follow up Study
The study objective is to assess the safety and efficacy of iTind three to five years
 following treatment.
This study will recruit patients who participated in the MT-03 study in the iTind arm to
 assess the safety and efficacy of the iTind procedure at three to five years following
 treatment as demonstrated by reduction of symptoms measured by IPSS and QoL and improvement
 of functional parameters as measured by peak urinary flow and PVR. Sexual and erectile
 function will also be assessed alongside the incidence of any related late occurring adverse
 events.
Inclusion Criteria:

 1. Subject signed informed consent form (ICF)

 2. Subject who had participated in the MT-03 study in the iTind arm

 3. Subject able to comply with the study protocol.

 Exclusion Criteria:

 1. Any anatomical or physiological condition that in the opinion of the investigator
 likely to impede successful completion of the study

 2. Patients that are known to have had undergone an alternative surgical procedure for
 BPH during MT-03 study.